Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?
{{output}}
E-selectin, a cytoadhesive glycoprotein, is expressed on venular endothelial cells and mediates leukocyte localization to inflamed endothelium, the first step in inflammatory cell extravasation into tissue. Constitutive marrow endothelial E-selectin expression... ...